Allworth Financial’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Allworth Financial's IRMD Position: Q1 2026 in Review
Allworth Financial increased its iRadimed (IRMD) stake by 38% in Q1 2026, buying an estimated $1.8K and bringing the position to 65 shares worth $6.26K. The position accounts for ﹤0.01% of the portfolio, ranked #3818.
Allworth Financial first reported a position in IRMD in Q4 2021 and has held it in 5 quarters since. The position peaked at $9K in Q4 2021. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Allworth Financial held 65 shares of iRadimed worth $6.26K as of Q1 2026.
- Allworth Financial bought 18 iRadimed shares in Q1 2026, an estimated $1.8K.
- iRadimed made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #3818 holding.
- Allworth Financial first reported a position in iRadimed in Q4 2021 and has held it in 5 quarters since.
- Allworth Financial's iRadimed position peaked at $9K in Q4 2021.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.